Skip to content

Follow-up of the Rotator Cuff Calcific Tendonitis trial: - Needle US-guided treatment vs. Subacromial corticosteroids -

Follow-up of the Rotator Cuff Calcific Tendonitis trial: - Needle US-guided treatment vs. Subacromial corticosteroids - - RCCT-2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42504
Enrollment
48
Registered
2015-11-20
Start date
2015-12-15
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

calcifying tendonitis shoulder calcific depositis

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Included in original RCCT trial (P09.239)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Mid-term Constant Score (4-5 years).

Secondary

MeasureTime frame
WORC, DASH, VAS scores for pain, anchor questions, aspect, location and classification (including Gärtner score) of eventual calcifications and the state of the rotator cuff (e.g. tendonitis or rupture y/n).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)